ZXBio, Inc.

Private

HuzhouHealthcare & Life Scienceshttps://zxbiopharm.com/

Last Round

Series A

Extension

Nov 6, 2024

Total Funding Raised

$2.17M

Company Overview

ZXBio, Inc. is a biotechnology company that develops and produces monoclonal antibodies, antibody-based research and diagnostic reagents, and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

monoclonal antibodiesflow cytometrydiagnostic kitsIVDin vitro diagnosticdiagnostic reagentsclinical diagnosticslab reagentsclinical laboratory servicesdiagnostic hardwarebiotech manufacturinglab testingdomestic substitutionantibody production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZXBio, Inc. Comps

Public and private peers based on sector, stage, and business model.

ZXBio, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ZXBio, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Nov 6, 2024
Series A Extension	Oct 7, 2023
Series A	Jun 9, 2022
Angel	Sep 1, 2020
Grant	Sep 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Yang Zhang

Chairperson & CEO

Executive Team

ZXBio, Inc. Investors

Notable investors and investment history

ZXBio, Inc. investors
Investor	Rounds
Huiyu Investment (Huizhi Group)	Series A Extension

View all Investors

ZXBio, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ZXBio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZXBio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHuzhou

Employee Range2

Year Founded2017

Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.